rss
Sex Transm Infect 2004;80:342-348 doi:10.1136/sti.2003.006197
  • Chlamydia

The chlamydia screening studies: rationale and design

  1. N Low1,
  2. A McCarthy1,
  3. J Macleod2,
  4. C Salisbury3,
  5. P J Horner4,
  6. T E Roberts7,
  7. R Campbell1,
  8. A Herring5,
  9. S Skidmore6,
  10. E Sanford1,
  11. J A C Sterne1,
  12. G Davey Smith1,
  13. A Graham3,
  14. M Huengsberg8,
  15. J Ross8,
  16. M Egger1,
  17. for the Chlamydia Screening Studies (ClaSS) Group
  1. 1Department of Social Medicine, University of Bristol, Bristol BS8 2PR, UK
  2. 2Department of Primary Care, University of Birmingham, Birmingham B15 2TT, UK
  3. 3Primary Health Care, University of Bristol, Bristol BS6 6JL, UK
  4. 4The Milne Centre, United Bristol Healthcare Trust, Bristol BS2 8HW, UK
  5. 5Public Health Laboratory Service Bristol Laboratory, Bristol BS2 8EL, UK
  6. 6Public Health Laboratory Service Birmingham Laboratory, Birmingham B9 5ST, UK
  7. 7Health Services Management Centre, University of Birmingham B15 2RT, UK
  8. 8Whittall Street Clinic, Heart of Birmingham Primary Care Trust, Birmingham B4 6DH, UK
  1. Correspondence to:
 Dr N Low
 Department of Social Medicine, University of Bristol, Canynge Hall, Whiteladies Road, Bristol BS8 2PR, UK; nicola.lowbristol.ac.uk
  • Accepted 9 February 2004

Abstract

Background: Screening has been recommended to reduce the prevalence and morbidity associated with genital chlamydia infection in the United Kingdom.

Methods: We describe the rationale and study design of the Chlamydia Screening Studies (ClaSS), a collaborative project designed to evaluate screening outside genitourinary medicine clinics. A non-selective, active screening approach in 16–39 year olds randomly sampled from 27 general practice lists in the Bristol and Birmingham areas formed the basis of interlinked studies: a case-control study was used to investigate factors to improve the targeting of screening; participants with chlamydia were invited to enrol in a randomised controlled trial to evaluate partner notification conducted in primary care; and laboratory based studies were used to assess the best specimens and tests. We also explored psychosocial effects of screening and partner notification and modelled the cost effectiveness of the programme.

Conclusion: Results from four pilot practices show that mailing of specimens for chlamydia testing is feasible but that it is difficult to achieve high response rates with postal screening. The high prevalence of asymptomatic infection in men suggests that efforts to screen men for chlamydia should be strengthened.

Footnotes

    This Article

    1. Abstract
    2. Full text
    3. PDF

    Responses

    1. Submit a response
    2. No responses published

    Register for free content

    The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

    Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.